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Calendula officinalis, known as Pot Marigold or English Marigold, is a plant in the Calendula genus. 
Calendula officinalis is used for the treatment of skin disorders and pain, and as a bactericide, 
antiseptic and anti-inflammatory. The petals and pollen contain triterpenoid esters (an anti-
inflammatory) and the carotenoids flavoxanthin and auroxanthin (antioxidants, and the source of the 
yellow-orange coloration). The leaves and stems contain other carotenoids, mostly lutein (80%) 
and zeaxanthin (5%), and beta-carotene. Plant extracts are also widely used by cosmetics, presumably 
due to presence of compounds such as saponins, resins and essential oils.
 
Phagocytosis
Three polysaccharides isolated from an aqueous extract of Flos Calendulae enhanced phagocytosis in 
human granulocytes in vitro in the colloidal carbon clearance test1. Intraperitoneal injection of a 
polysaccharide fraction isolated from an aqueous extract of the flowers to mice (10 mg/kg body 
weight) enhanced phagocytosis4. Intraperitoneal administration of an unsaponifiable fraction (0.5 ml) 
of a hydroalcoholic extract of the flowers weakly stimulated phagocytosis in mice inoculated with 
Escherichia coli. However, the hydroalcoholic extract was not active5.
 
Antimicrobial activity
The essential oil of the flowers inhibited the growth in vitro of Bacillus subtilis, Escherichia coli, 
Staphylococcus aureus, Pseudomonas aeruginosa and Candida albican6. A flavonoid fraction isolated 
from the flowers inhibited the growth in vitro of S. aureus, Sarcina lutea, E. coli, Klebsiella 
pneumoniae and Candida monosa7. However, chloroform, ethanol, methanol or water extracts of the 
flowers did not inhibit bacterial growth in vitro8-10. Acetone, ethanol or water extracts inhibited the 
growth in vitro of the fungus Neurospora crassa11. Extracts of the flowers inhibited the growth in vitro 
of Trichomonas vaginalis12. Oxygenated terpenes appear to be responsible for the antimicrobial 
activity13.
 
Antiviral activity
A tincture of the flowers suppressed the replication of herpes simplex, influenza A2 and influenza 
APR-8 viruses in vitro14. However, an aqueous extract of the flowers was not active14. A chloroform 
extract of the flowers inhibited the replication of HIV-1 in acutely infected lymphocytic MOLT-4 cells 
in vitro (IC50 0.4 mg/ml)15. A chloroform extract also inhibited HIV-1 reverse transcriptase activity in 
a dose-dependent manner (ED50 51.0 mg/ml). A 5% hot aqueous extract of the flowers (2 ml) 
inhibited the replication of encephalitis virus after intraperitoneal administration to mice16.
 
Anti-inflammaory activity
Topical application of a 70% ethanol extract of the flowers to mice at a dose of 1.2 mg/ear 
(corresponding to 4.16 mg crude drug) reduced croton oil-induced ear oedema by 20%17. External 
application of a carbon dioxide extract of the flowers (300 mg/cm2) suppressed croton oil-induced ear 
oedema in mice18. The triterpene fraction of an extract of the flowers had marked anti-inflammatory 
activity in mice (1 mg/ear) against ear oedema induced by 12-Otetradecanoylphorbol- 13-acetate19. 
Faradiol esters isolated from the flowers (240 mg/cm2) inhibited croton oil-induced ear oedema in 
mice20. Intragastric administration of an aqueous extract of the flowers (100 mg/kg body weight) 
inhibited carrageenan-induced footpad oedema in rats21. However, an 80% ethanol extract of the 
flowers was weakly active (11% inhibition) at a concentration of 100 mg/kg body weight administered 
orally 1 hour prior to induction of oedema22. Isorhamnetin glycosides isolated from the 
flowersinhibited rat lung lipoxygenase in vitro23.
 
Wound-healing activity 
External application of a hydroalcoholic extract accelerated the rate of contraction and epithelialization 
of excision wounds in rats24. A 3% freeze-dried aqueous extract of the flowers induced vascularization 
in the chick chorioallantoic membrane assay. Histological sections of the treated chorioallantoic 
membranes also indicated the presence of hyaluronan, a tissue glycosaminoglycan associated with 
neovascularization25.
 
Clinical pharmacology
Although no randomized, controlled clinical trials have been performed, two case reports in the early 
medical literature support the traditional use of Flos Calendulae. The reports describe the use of a 
strong tincture of the flowers applied on compresses to reduce inflammation and suppuration, and to 
accelerate the healing of wounds 26, 27. 
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